Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings worldwide.See below for updated list of upcoming events.

DIA (the Drug Information Association), 2017 18 - 22 June, 2017 | Chicago, USARichmond Pharmacology’s Principal Investigators Dr Taubel and Dr Lorch will be presenting at DIA 2017,ChicagoJoin our CEO Dr Jorg Taubel, who will be presenting on the topic ‘Combined Adaptive Early Phase Trials: From First-Time-in-Human to Proof of Concept in One Protocol’ Tuesday AM – 20th of June.Dr Ulrike Lorch will also be in attendance presenting ‘Combined Adaptive Early Phase Trials: From First-Time-in-Human to Proof of Concept in One Protocol’ her presentation will also take place Tuesday AM –20th June.For more information visit: DIA-2017

Latest news

Richmond Pharmacology Welcomes Back Dr Edward Jackson as Medical Director

November 3, 2025
Richmond Pharmacology is pleased to announce the return of Dr Edward Jackson, who re-joins the organisation as Medical Director.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event